241 related articles for article (PubMed ID: 30082142)
1. The prognostic value of COX-2 expression on circulating tumor cells in nasopharyngeal carcinoma: A prospective analysis.
Li YJ; Luo Y; Xie XQ; Li P; Wang F
Radiother Oncol; 2018 Nov; 129(2):396-402. PubMed ID: 30082142
[TBL] [Abstract][Full Text] [Related]
2. Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patients.
You R; Liu YP; Lin M; Huang PY; Tang LQ; Zhang YN; Pan Y; Liu WL; Guo WB; Zou X; Zhao KM; Kang T; Liu LZ; Lin AH; Hong MH; Mai HQ; Zeng MS; Chen MY
Int J Cancer; 2019 Nov; 145(10):2873-2883. PubMed ID: 31044420
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of circulating tumor cells and their expression of cyclooxygenase-2 in patients with nasopharyngeal carcinoma.
Xie XQ; Luo Y; Ma XL; Li SS; Liu L; Zhang H; Li P; Wang F
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6951-6961. PubMed ID: 31486495
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of circulating tumor cell measurement in the peripheral blood of patients with nasopharyngeal carcinoma.
Gao T; Mao J; Huang J; Luo F; Lin L; Lian Y; Bin S; Zhao L; Li S
Clinics (Sao Paulo); 2023; 78():100179. PubMed ID: 36963168
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Excision Repair Cross-Complementation Group 1 on Circulating Tumor Cells for Nasopharyngeal Carcinoma.
Liu T; Li Y; Song J; Li B; Wang R; Huang T; Qin Y
Cancer Control; 2024; 31():10732748241251562. PubMed ID: 38716503
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells: a valuable marker of poor prognosis for advanced nasopharyngeal carcinoma.
Ou G; Xing S; Li J; Zhang L; Chen S
Mol Med; 2019 Nov; 25(1):50. PubMed ID: 31729954
[TBL] [Abstract][Full Text] [Related]
7. Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
Fu X; Shen C; Wang H; Chen F; Li G; Wen Z
BMC Cancer; 2017 Jul; 17(1):479. PubMed ID: 28693532
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N
BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of the Pretreatment Primary Lesion Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Nasopharyngeal Carcinoma.
Qin Y; Yu X; Hou J; Hu Y; Li F; Wen L; Lu Q; Liu S
Acad Radiol; 2019 Nov; 26(11):1473-1482. PubMed ID: 30772137
[TBL] [Abstract][Full Text] [Related]
10. Pre-treatment amide proton transfer imaging predicts treatment outcome in nasopharyngeal carcinoma.
Qamar S; King AD; Ai QH; Mo FKF; Chen W; Poon DMC; Tong M; Ma BB; Yeung DK; Wang YX; Yuan J
Eur Radiol; 2020 Nov; 30(11):6339-6347. PubMed ID: 32588210
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of serum bilirubin in southern Chinese patients with advanced nasopharyngeal carcinoma.
Yao JJ; Kou J; Peng QH; Dong J; Zhang WJ; Lawrence WR; Zhang F; Zhou GQ; Wang SY; Sun Y
Clin Chim Acta; 2018 Sep; 484():314-319. PubMed ID: 29860034
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of circulating tumor cells in patients with locally advanced head and neck squamous cell carcinoma.
Liu K; Chen N; Wei J; Ma L; Yang S; Zhang X
Oncol Rep; 2020 May; 43(5):1525-1535. PubMed ID: 32323844
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy.
Ling F; Xu S; Li X; Sun X; Long W
BMC Cancer; 2023 Feb; 23(1):169. PubMed ID: 36803974
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of serial analysis of circulating tumour cells for detection of minimal residual disease of metastatic nasopharyngeal carcinoma.
Ko JM; Vardhanabhuti V; Ng WT; Lam KO; Ngan RK; Kwong DL; Lee VH; Lui YH; Yau CC; Kwan CK; Li WS; Yau S; Guo C; Choi SSA; Lei LC; Chan KC; Lam CC; Chan CK; Dai W; Khong PL; Lung ML
Br J Cancer; 2020 Jul; 123(1):114-125. PubMed ID: 32372027
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of circulating tumor cells and its association with the expression of cancer stem cells in nasopharyngeal carcinoma patients.
Lu L; Huang HW; Du H; Liu ZX; Zha ZQ; Wang PP; Wu Y; Liu X; Weng CY; Fang XS; Li BX; Mao HB; Wang LN; Wang XP; Guan MM; Liu GL
Neoplasma; 2022 Mar; 69(2):303-310. PubMed ID: 35068161
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of the Albumin-to-Alkaline Phosphatase Ratio before Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma.
Yang L; Gao J; Zhou Y; Tao Z; He J; Yang J; Wang R; Zhang Y; Huang Y; Zhou L; Sun B
Chemotherapy; 2021; 66(1-2):40-46. PubMed ID: 33601377
[TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor Cells Correlate With Prognosis in Head and Neck Squamous Cell Carcinoma.
Zhou S; Wang L; Zhang W; Liu F; Zhang Y; Jiang B; Wang J; Yuan H
Technol Cancer Res Treat; 2021; 20():1533033821990037. PubMed ID: 33641530
[TBL] [Abstract][Full Text] [Related]
19. Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT.
Zhang Z; Huang J; Wang G; Jin F; Zheng J; Xiao H; Lei L; Luo J; Chen C
BMC Cancer; 2020 Mar; 20(1):183. PubMed ID: 32131777
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy in local-regionally advanced nasopharyngeal carcinoma: A National Cancer Database analysis.
Tam M; Lee A; Wu SP; Gerber NK; Li Z; Givi B; Hu K; Schreiber D
Laryngoscope; 2018 Dec; 128(12):2770-2777. PubMed ID: 30133799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
